Syngene International Limited (NSE:SYNGENE)
India · Delayed Price · Currency is INR 415.60
-3.15 (-0.75%)
At close: Mar 27, 2026
Syngene International Market Cap
Syngene International has a market cap or net worth of 165.45 billion as of March 27, 2026. Its market cap has decreased by -39.58% in one year.
Market Cap
165.45B
Enterprise Value
160.35B
Revenue
37.20B
Ranking
n/a
PE Ratio
52.21
Stock Price
415.60
Market Cap Chart
Since August 11, 2015, Syngene International's market cap has increased from 62.11B to 165.45B, an increase of 166.38%. That is a compound annual growth rate of 9.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 165.45B | -36.16% |
| Dec 31, 2025 | 259.16B | -24.09% |
| Dec 31, 2024 | 341.40B | 22.54% |
| Dec 29, 2023 | 278.60B | 19.79% |
| Dec 30, 2022 | 232.57B | -5.39% |
| Dec 31, 2021 | 245.81B | -3.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.30T |
| Divi's Laboratories | 1.59T |
| Apollo Hospitals Enterprise | 1.09T |
| Cipla | 1.00T |
| Sagility | 195.45B |
| Wockhardt | 193.28B |
| Piramal Pharma | 190.63B |
| Eris Lifesciences | 185.77B |